Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
NCT05045066
This study is recruiting at 2 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
This early phase I is to find out how common vitamin D insufficiency is among African American patients with a history of prostate cancer that has not spread to other parts of the body (localized) or has spread to other places in the body (metastatic) and how vitamin D insufficiency affects the immune system. This study also aims to find out if replacing vitamin D results in normalization of the immune function.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Localized Prostate Carcinoma
- Stage IV Prostate Cancer AJCC v8
- Locally Recurrent Prostate Carcinoma
- Metastatic Prostate Carcinoma
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Early Phase 1
- Ages
- 18 years and older
- Sex
- Male
- Healthy volunteers
- Not accepted
- Sponsor
- Mayo Clinic
- Last updated on ClinicalTrials.gov
- October 13, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- Mayo Clinic in Arizona · Scottsdale, AZ
Florida · 1
- Mayo Clinic in Florida · Jacksonville, FL
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.